Publications by authors named "Alison Donald"

Claim this Profile
P
Public Health.
Connor Snow, Sophie Berghmans, Quinn Smith, Alison Donald, Matiram Pun

Alzheimers Dement· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-related changes in sleep architecture: Effects of body mass index, sex, and mental health in community-dwelling adults using at-home polysomnography.
Shane Magnison-Benoit, Connor Snow, Matiram Pun, Harshita Gauba, Sophie Berghmans, Alison M H Donald

Sleep Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal Proteomic Profiling of Cognition across an Aerobic Exercise Intervention.
Alison M H Donald, Luiz G N de Almeida, Mohamed Ziad Dabaja, Isabella Orchard, Kaia Ybema

Ann Neurol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review and Meta-Analysis to Estimate the Treatment Effect and Inform a Noninferiority Margin for a Phase 3 Noninferiority Trial in Uncomplicated Urogenital Gonorrhea.
Fanny S Mitrani-Gold, Jonathan Fix, Alison Donald

Sex Transm Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Negative Food Effect of Danirixin: Use of PBPK Modelling to Explore the Effect of Formulation and Meal Type on Clinical PK.
Richard S Lloyd, Martin I Hingle, Jackie C Bloomer, Stephen J Charles, James M Butler, Donald D'Amico, Alison Donald

Pharm Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial.
Aili L Lazaar, Bruce E Miller, Alison C Donald, Thomas Keeley, Claire Ambery

Respir Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of umeclidinium/vilanterol on exercise endurance in COPD: a randomised study.
John H Riley, Chris J Kalberg, Alison Donald, David A Lipson, Muhammad Shoaib

ERJ Open Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 μg on health-related quality of life in patients with COPD.
Thomas M Siler, Alison C Donald, Dianne O'Dell, Alison Church, William A Fahy

Int J Chron Obstruct Pulmon Dis· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correct usage, ease of use, and preference of two dry powder inhalers in patients with COPD: analysis of five phase III, randomized trials.
John H Riley, Maggie Tabberer, Nathalie Richard, Alison Donald, Alison Church

Int J Chron Obstruct Pulmon Dis· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studies.
Thomas M Siler, Edward Kerwin, Ana R Sousa, Alison Donald, Rehan Ali

Respir Med· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of a combination of umeclidinium/vilanterol on exercise endurance in patients with chronic obstructive pulmonary disease: two randomized, double-blind clinical trials.
François Maltais, Sally Singh, Alison C Donald, Glenn Crater, Alison Church

Ther Adv Respir Dis· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of once-daily GW870086 a novel selective glucocorticoid in mild-moderate asthmatics: a randomised, two-way crossover, controlled clinical trial.
Philippe Bareille, Kelly Hardes, Alison C Donald

J Asthma· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability and pharmacokinetics and pharmacodynamics of inhaled once-daily umeclidinium in healthy adults deficient in CYP2D6 activity: a double-blind, randomized clinical trial.
Anthony Cahn, Rashmi Mehta, Andrew Preece, James Blowers, Alison Donald

Clin Drug Investig· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empirical assessment suggests that existing evidence could be used more fully in designing randomized controlled trials.
Alison C Goudie, Alexander J Sutton, David R Jones, Alison Donald

J Clin Epidemiol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An encouraging assessment of methods to inform priorities for updating systematic reviews.
Alex J Sutton, Sarah Donegan, Yemisi Takwoingi, Paul Garner, Carol Gamble, Alison Donald

J Clin Epidemiol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between tooth wear, habitat quality and late-life reproduction in a wild red deer population.
Daniel H Nussey, Bonnie Metherell, Kelly Moyes, Alison Donald, Fiona E Guinness

J Anim Ecol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The rate of senescence in maternal performance increases with early-life fecundity in red deer.
Daniel H Nussey, Loeske E B Kruuk, Alison Donald, Martin Fowlie, Tim H Clutton-Brock

Ecol Lett· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis